Coherent's Q2 results showed impressive revenue growth of 27% y/y, driven by a 79% y/y increase in the datacom segment. Read ...
Anavex Life Sciences Corp. expects feedback from the European Medicines Agency on blarcamesine for Alzheimer's Disease this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback